Combining Crocin and Sorafenib Improves Their Tumor-Inhibiting Effects in a Rat Model of Diethylnitrosamine-Induced Cirrhotic-Hepatocellular Carcinoma

SIMPLE SUMMARY: Liver cancer represents one of the most lethal forms of cancer, with hepatocellular carcinoma (HCC) accounting for the majority of its incidences and deaths. Currently, sorafenib is the first-in-line option for treating advanced and unresectable HCC. It is a multi-kinase inhibitor th...

Descripción completa

Detalles Bibliográficos
Autores principales: Awad, Basma, Hamza, Alaaeldin Ahmed, Al-Maktoum, Amna, Al-Salam, Suhail, Amin, Amr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452334/
https://www.ncbi.nlm.nih.gov/pubmed/37627094
http://dx.doi.org/10.3390/cancers15164063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452334/
https://www.ncbi.nlm.nih.gov/pubmed/37627094
http://dx.doi.org/10.3390/cancers15164063

Ejemplares similares